Inhibition of Leishmania (Leishmania) amazonensis growth and infectivity by aureobasidin A

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 3, 2007, Pages 487-492

  Tanaka, Ameria K ^a   Valero, Valderez B ^a   Takahashi, Helio K ^a   Straus, Anita H ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amastigotes; Anti Leishmania; Sphingolipids

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMPHOTERICIN B; AUREOBASIDIN A; LIPID; SPHINGOLIPID; DEPSIPEPTIDE; ENZYME INHIBITOR; GLYCOSPHINGOLIPID; INOSITOLPHOSPHORYLCERAMIDE; UNCLASSIFIED DRUG;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DOSE RESPONSE; ENZYME INHIBITION; FOOT PAD; GROWTH CURVE; GROWTH INHIBITION; IC 50; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; INOCULATION; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIA MAJOR; LEISHMANIASIS; LIPID METABOLISM; MICROBIAL GROWTH; MOUSE; NONHUMAN; PARASITE VIABILITY; PERITONEUM MACROPHAGE; PROMASTIGOTE; PROTOZOAL INFECTION; RISK REDUCTION; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; LEISHMANIA MEXICANA; MACROPHAGE; METABOLISM; PARASITOLOGY; PATHOGENICITY;

ANIMALS; DEPSIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLYCOSPHINGOLIPIDS; LEISHMANIA MEXICANA; MACROPHAGES; MICE; MICE, INBRED BALB C;

EID: 34248162448     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl518     Document Type: Article

References (21)

1. Hakomori S. Structure and function of sphingolipids in transmembrane signalling and cell-cell interactions. Biochem Soc Trans 1993; 21: 583-95.
2. Dietrich C, Bagatolli LA, Volovyk ZN et al. Lipid rafts reconstituted in model membranes. Biophys J 2001; 80: 1417-28.
3. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000; 1: 31-9.
4. Denny PW, Smith DF. Rafts and sphingolipid biosynthesis in the kinetoplastid parasitc protozoa. Mol Microbiol 2004; 53: 725-33.
5. Denny PW, Goulding D, Ferguson MA et al.. Sphingolipid-free Leishmania are defective in membrane trafficking, differentiation and infectivity. Mol Microbiol 2004; 52: 313-27.
6. McConville MJ, Bacic A. A family of glycoinositol phospholipids from Leishmania major. Isolation, characterization, and antigenicity. J Biol Chem 1989; 264: 757-66.
7. Kaneshiro ES, Jayasimhulu K, Lester RL. Characterization of inositol lipids in Leishmania donovani promastigotes: Identification of an inisitoil sphingolipid. J Lipid Res 1986; 27: 1294-303.
8. Endo M, Takessako K, Kato I et al. Fungicidal action of aureobasidin A, a cyclic depsipeptide antifungal antibiotic, against Saccharomyces cerevisiae. Antimicrob Agents Chemother 1997; 41: 672-6.
9. Takesako K, Kuroda H, Inoue T et al. Biological properties of Aureobasidin A, a cyclic depsipeptide antifungal antibiotic. J Antibiot (Tokyo) 1993; 46: 1414-20.
10. Sonda S, Sala G, Ghidoni R et al. Inhibitory effect of aureobasidin A on Toxoplasma gondii. Antimicrob Agents Chemother 2005; 49: 1794-801.
11. Salto ML, Bertello ME, Vieira M et al. Formation and remodeling of inositolphosphoceramide during differentiation of Trypanosoma cruzi from trypomastigote to amastigote. Eukaryot Cell 2003; 2: 756-68.
12. Camargo EP. Growth and differentiation in Trypanosoma cruzi. I. Origin of metacyclic trypanosomes in liquid media. Rev Inst Med Trop São Paulo 1964; 12: 93-100.
13. Straus AH, Levery SB, Jasiulionis MG et al. Stage-specific glycosphingolipids from amastigote forms of Leishmania (L.) amazonensis. J Biol Chem 1993; 268: 3723-30.
14. Dutta A, Bandyopadhyay S, Mandal C et al. Development of a modified MTT assay for screening antimonial resistant field isolates of Indian visceral leishmaniasis. Parasitol Intern 2005; 54: 119-22.
15. Suzuki E, Tanaka AK, Takahashi HK et al. Role of β-D-galactofuranose in Leishmania major macrophage invasion. Infect Immun 2002; 70: 6592-6.
16. Silveira TGV, Yoneyama KAG, Takahashi H. et al. Isolation of Leishmania (Viannia) braziliensis glycolipid antigens and their reactivity with mAb SST-1, specific for parasites of Viannia subgenus. Parasitology 2005; 131: 737-45.
17. Becker GW, Lester RL. Biosynthesis of phosphoinositol-containing sphingolipids from phosphatidylinositol by a membrane preparation from Saccharomyces cerevisiae. J Bacteriol 1980; 142: 747-54.
18. Zhang K, Showalter M, Revollo J et al. Sphingolipids are essential for differentiation but not growth in Leishmania. EMBO J 2003; 22: 6016-26.
19. Zhang K, Hsu F-F, Scott DA et al. Leishmania salvage and remodelling of host sphingolipids in amastigote survival and acidocalcisome biogenesis. Mol Microbiol 2005; 55, 1566-78.
20. Spiegel S, Milstien S. Sphingosine 1-phosphate, a key cell signaling molecule. J Biol Chem 2002; 277: 25851-4.
21. Maceyka M, Milstien S, Spiegel S. Sphingosine kinases, sphingosine-1-phosphate and sphingolipidomics. Prostaglandins Other Lipid Mediat 2005; 77: 15-22.